世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

Pegvisomantの世界市場に関する洞察と2028年までの予測

Pegvisomantの世界市場に関する洞察と2028年までの予測


Global Pegvisomant Market Insights and Forecast to 2028

Pegvisomant（商品名Somavert）は、先端巨大症の治療に使用される成長ホルモン受容体拮抗薬です。 市場分析および洞察。ペグビソマントの世界市場 COVID-19の流行により、Pegvisomantの世界市場規模は2022年に... もっと見る

　

　

出版社 出版年月 電子版価格 納期 言語
QYResearch
QYリサーチ 		2022年2月18日 US$4,900
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら 		5-7営業日 英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


　

サマリー

Pegvisomant（商品名Somavert）は、先端巨大症の治療に使用される成長ホルモン受容体拮抗薬です。
市場分析および洞察。ペグビソマントの世界市場
COVID-19の流行により、Pegvisomantの世界市場規模は2022年に百万米ドル相当と推定され、レビュー期間中にCAGR %で2028年までに百万米ドルに再調整されると予測されています。この健康危機による経済変化を十分に考慮し、2021年にPegvisomant世界市場の％を占めたPrefilledは、2028年までに100万米ドルの価値を持ち、COVID-19後の期間に修正された％のCAGRで成長すると予測されます。一方、病院部門は、この予測期間中、年平均成長率（%）に変更されています。

2021年の中国Pegvisomantの市場規模は100万米ドル、米国と欧州のPegvisomantはそれぞれ100万米ドル、100万米ドルと評価されています。2021年の米国の割合は％、中国と欧州はそれぞれ％と％であり、中国の割合は2028年には％に達すると予測され、分析期間を通じてCAGRは％となります。日本、韓国、東南アジアはアジアで注目すべき市場であり、今後6年間のCAGRはそれぞれ％、％、％となっています。ヨーロッパのPegvisomantの展望については、ドイツは2028年までに100万米ドルに達すると予測され、予測期間中のCAGRは%となっています。
Pegvisomantの世界的な主要メーカーには、Pfizerなどがあります。2021年には、世界の上位5社が売上高で約 %のシェアを獲得しています。

世界のペグビソマントの範囲とセグメント
ペグビソマント市場は、タイプ別と用途別に分類されます。世界のPegvisomant市場におけるプレイヤー、ステークホルダー、その他の参加者は、このレポートを強力なリソースとして利用することで、優位に立つことができるようになるでしょう。セグメント別分析では、2017年から2028年までのタイプ別およびアプリケーション別の売上、収益、予測に焦点を当てています。

タイプ別セグメント
プレフィルド
ノンプレフィルド
用途別セグメント
病院
薬局

会社別
ファイザー

地域別
北アメリカ
米国
カナダ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
アジア太平洋地域
中国
日本
韓国
インド
オーストラリア
中国 台湾
インドネシア
タイ
マレーシア
中南米
メキシコ
ブラジル
アルゼンチン
中東・アフリカ
トルコ
サウジアラビア
UAE


ページTOPに戻る


目次

1 Study Coverage
1.1 Pegvisomant Product Introduction
1.2 Market by Type
1.2.1 Global Pegvisomant Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Prefilled
1.2.3 Non-prefilled
1.3 Market by Application
1.3.1 Global Pegvisomant Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Pegvisomant Sales Estimates and Forecasts 2017-2028
2.2 Global Pegvisomant Revenue Estimates and Forecasts 2017-2028
2.3 Global Pegvisomant Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Pegvisomant Sales by Region
2.4.1 Global Pegvisomant Sales by Region (2017-2022)
2.4.2 Global Sales Pegvisomant by Region (2023-2028)
2.5 Global Pegvisomant Revenue by Region
2.5.1 Global Pegvisomant Revenue by Region (2017-2022)
2.5.2 Global Pegvisomant Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Pegvisomant Sales by Manufacturers
3.1.1 Global Top Pegvisomant Manufacturers by Sales (2017-2022)
3.1.2 Global Pegvisomant Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Pegvisomant in 2021
3.2 Global Pegvisomant Revenue by Manufacturers
3.2.1 Global Pegvisomant Revenue by Manufacturers (2017-2022)
3.2.2 Global Pegvisomant Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Pegvisomant Revenue in 2021
3.3 Global Pegvisomant Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Pegvisomant Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Pegvisomant Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Pegvisomant Sales by Type
4.1.1 Global Pegvisomant Historical Sales by Type (2017-2022)
4.1.2 Global Pegvisomant Forecasted Sales by Type (2023-2028)
4.1.3 Global Pegvisomant Sales Market Share by Type (2017-2028)
4.2 Global Pegvisomant Revenue by Type
4.2.1 Global Pegvisomant Historical Revenue by Type (2017-2022)
4.2.2 Global Pegvisomant Forecasted Revenue by Type (2023-2028)
4.2.3 Global Pegvisomant Revenue Market Share by Type (2017-2028)
4.3 Global Pegvisomant Price by Type
4.3.1 Global Pegvisomant Price by Type (2017-2022)
4.3.2 Global Pegvisomant Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Pegvisomant Sales by Application
5.1.1 Global Pegvisomant Historical Sales by Application (2017-2022)
5.1.2 Global Pegvisomant Forecasted Sales by Application (2023-2028)
5.1.3 Global Pegvisomant Sales Market Share by Application (2017-2028)
5.2 Global Pegvisomant Revenue by Application
5.2.1 Global Pegvisomant Historical Revenue by Application (2017-2022)
5.2.2 Global Pegvisomant Forecasted Revenue by Application (2023-2028)
5.2.3 Global Pegvisomant Revenue Market Share by Application (2017-2028)
5.3 Global Pegvisomant Price by Application
5.3.1 Global Pegvisomant Price by Application (2017-2022)
5.3.2 Global Pegvisomant Price Forecast by Application (2023-2028)
6 North America
6.1 North America Pegvisomant Market Size by Type
6.1.1 North America Pegvisomant Sales by Type (2017-2028)
6.1.2 North America Pegvisomant Revenue by Type (2017-2028)
6.2 North America Pegvisomant Market Size by Application
6.2.1 North America Pegvisomant Sales by Application (2017-2028)
6.2.2 North America Pegvisomant Revenue by Application (2017-2028)
6.3 North America Pegvisomant Market Size by Country
6.3.1 North America Pegvisomant Sales by Country (2017-2028)
6.3.2 North America Pegvisomant Revenue by Country (2017-2028)
6.3.3 the United States
6.3.4 Canada
7 Europe
7.1 Europe Pegvisomant Market Size by Type
7.1.1 Europe Pegvisomant Sales by Type (2017-2028)
7.1.2 Europe Pegvisomant Revenue by Type (2017-2028)
7.2 Europe Pegvisomant Market Size by Application
7.2.1 Europe Pegvisomant Sales by Application (2017-2028)
7.2.2 Europe Pegvisomant Revenue by Application (2017-2028)
7.3 Europe Pegvisomant Market Size by Country
7.3.1 Europe Pegvisomant Sales by Country (2017-2028)
7.3.2 Europe Pegvisomant Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 UK
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Pegvisomant Market Size by Type
8.1.1 Asia Pacific Pegvisomant Sales by Type (2017-2028)
8.1.2 Asia Pacific Pegvisomant Revenue by Type (2017-2028)
8.2 Asia Pacific Pegvisomant Market Size by Application
8.2.1 Asia Pacific Pegvisomant Sales by Application (2017-2028)
8.2.2 Asia Pacific Pegvisomant Revenue by Application (2017-2028)
8.3 Asia Pacific Pegvisomant Market Size by Region
8.3.1 Asia Pacific Pegvisomant Sales by Region (2017-2028)
8.3.2 Asia Pacific Pegvisomant Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Pegvisomant Market Size by Type
9.1.1 Latin America Pegvisomant Sales by Type (2017-2028)
9.1.2 Latin America Pegvisomant Revenue by Type (2017-2028)
9.2 Latin America Pegvisomant Market Size by Application
9.2.1 Latin America Pegvisomant Sales by Application (2017-2028)
9.2.2 Latin America Pegvisomant Revenue by Application (2017-2028)
9.3 Latin America Pegvisomant Market Size by Country
9.3.1 Latin America Pegvisomant Sales by Country (2017-2028)
9.3.2 Latin America Pegvisomant Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Pegvisomant Market Size by Type
10.1.1 Middle East and Africa Pegvisomant Sales by Type (2017-2028)
10.1.2 Middle East and Africa Pegvisomant Revenue by Type (2017-2028)
10.2 Middle East and Africa Pegvisomant Market Size by Application
10.2.1 Middle East and Africa Pegvisomant Sales by Application (2017-2028)
10.2.2 Middle East and Africa Pegvisomant Revenue by Application (2017-2028)
10.3 Middle East and Africa Pegvisomant Market Size by Country
10.3.1 Middle East and Africa Pegvisomant Sales by Country (2017-2028)
10.3.2 Middle East and Africa Pegvisomant Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Overview
11.1.3 Pfizer Pegvisomant Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Pfizer Pegvisomant Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Pegvisomant Industry Chain Analysis
12.2 Pegvisomant Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Pegvisomant Production Mode & Process
12.4 Pegvisomant Sales and Marketing
12.4.1 Pegvisomant Sales Channels
12.4.2 Pegvisomant Distributors
12.5 Pegvisomant Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Pegvisomant Industry Trends
13.2 Pegvisomant Market Drivers
13.3 Pegvisomant Market Challenges
13.4 Pegvisomant Market Restraints
14 Key Findings in The Global Pegvisomant Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

　

ページTOPに戻る


　

Summary

Pegvisomant(trade name Somavert) is a growth hormone receptor antagonist used in the treatment of acromegaly.
Market Analysis and Insights: Global Pegvisomant Market
Due to the COVID-19 pandemic, the global Pegvisomant market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Prefilled accounting for % of the Pegvisomant global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospital segment is altered to an % CAGR throughout this forecast period.

China Pegvisomant market size is valued at US$ million in 2021, while the US and Europe Pegvisomant are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Pegvisomant landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Pegvisomant include Pfizer. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

Global Pegvisomant Scope and Segment
Pegvisomant market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Pegvisomant market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type
Prefilled
Non-prefilled
Segment by Application
Hospital
Pharmacy

By Company
Pfizer

By Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE



ページTOPに戻る


Table of Contents

1 Study Coverage
1.1 Pegvisomant Product Introduction
1.2 Market by Type
1.2.1 Global Pegvisomant Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Prefilled
1.2.3 Non-prefilled
1.3 Market by Application
1.3.1 Global Pegvisomant Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Pegvisomant Sales Estimates and Forecasts 2017-2028
2.2 Global Pegvisomant Revenue Estimates and Forecasts 2017-2028
2.3 Global Pegvisomant Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Pegvisomant Sales by Region
2.4.1 Global Pegvisomant Sales by Region (2017-2022)
2.4.2 Global Sales Pegvisomant by Region (2023-2028)
2.5 Global Pegvisomant Revenue by Region
2.5.1 Global Pegvisomant Revenue by Region (2017-2022)
2.5.2 Global Pegvisomant Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Pegvisomant Sales by Manufacturers
3.1.1 Global Top Pegvisomant Manufacturers by Sales (2017-2022)
3.1.2 Global Pegvisomant Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Pegvisomant in 2021
3.2 Global Pegvisomant Revenue by Manufacturers
3.2.1 Global Pegvisomant Revenue by Manufacturers (2017-2022)
3.2.2 Global Pegvisomant Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Pegvisomant Revenue in 2021
3.3 Global Pegvisomant Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Pegvisomant Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Pegvisomant Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Pegvisomant Sales by Type
4.1.1 Global Pegvisomant Historical Sales by Type (2017-2022)
4.1.2 Global Pegvisomant Forecasted Sales by Type (2023-2028)
4.1.3 Global Pegvisomant Sales Market Share by Type (2017-2028)
4.2 Global Pegvisomant Revenue by Type
4.2.1 Global Pegvisomant Historical Revenue by Type (2017-2022)
4.2.2 Global Pegvisomant Forecasted Revenue by Type (2023-2028)
4.2.3 Global Pegvisomant Revenue Market Share by Type (2017-2028)
4.3 Global Pegvisomant Price by Type
4.3.1 Global Pegvisomant Price by Type (2017-2022)
4.3.2 Global Pegvisomant Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Pegvisomant Sales by Application
5.1.1 Global Pegvisomant Historical Sales by Application (2017-2022)
5.1.2 Global Pegvisomant Forecasted Sales by Application (2023-2028)
5.1.3 Global Pegvisomant Sales Market Share by Application (2017-2028)
5.2 Global Pegvisomant Revenue by Application
5.2.1 Global Pegvisomant Historical Revenue by Application (2017-2022)
5.2.2 Global Pegvisomant Forecasted Revenue by Application (2023-2028)
5.2.3 Global Pegvisomant Revenue Market Share by Application (2017-2028)
5.3 Global Pegvisomant Price by Application
5.3.1 Global Pegvisomant Price by Application (2017-2022)
5.3.2 Global Pegvisomant Price Forecast by Application (2023-2028)
6 North America
6.1 North America Pegvisomant Market Size by Type
6.1.1 North America Pegvisomant Sales by Type (2017-2028)
6.1.2 North America Pegvisomant Revenue by Type (2017-2028)
6.2 North America Pegvisomant Market Size by Application
6.2.1 North America Pegvisomant Sales by Application (2017-2028)
6.2.2 North America Pegvisomant Revenue by Application (2017-2028)
6.3 North America Pegvisomant Market Size by Country
6.3.1 North America Pegvisomant Sales by Country (2017-2028)
6.3.2 North America Pegvisomant Revenue by Country (2017-2028)
6.3.3 the United States
6.3.4 Canada
7 Europe
7.1 Europe Pegvisomant Market Size by Type
7.1.1 Europe Pegvisomant Sales by Type (2017-2028)
7.1.2 Europe Pegvisomant Revenue by Type (2017-2028)
7.2 Europe Pegvisomant Market Size by Application
7.2.1 Europe Pegvisomant Sales by Application (2017-2028)
7.2.2 Europe Pegvisomant Revenue by Application (2017-2028)
7.3 Europe Pegvisomant Market Size by Country
7.3.1 Europe Pegvisomant Sales by Country (2017-2028)
7.3.2 Europe Pegvisomant Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 UK
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Pegvisomant Market Size by Type
8.1.1 Asia Pacific Pegvisomant Sales by Type (2017-2028)
8.1.2 Asia Pacific Pegvisomant Revenue by Type (2017-2028)
8.2 Asia Pacific Pegvisomant Market Size by Application
8.2.1 Asia Pacific Pegvisomant Sales by Application (2017-2028)
8.2.2 Asia Pacific Pegvisomant Revenue by Application (2017-2028)
8.3 Asia Pacific Pegvisomant Market Size by Region
8.3.1 Asia Pacific Pegvisomant Sales by Region (2017-2028)
8.3.2 Asia Pacific Pegvisomant Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Pegvisomant Market Size by Type
9.1.1 Latin America Pegvisomant Sales by Type (2017-2028)
9.1.2 Latin America Pegvisomant Revenue by Type (2017-2028)
9.2 Latin America Pegvisomant Market Size by Application
9.2.1 Latin America Pegvisomant Sales by Application (2017-2028)
9.2.2 Latin America Pegvisomant Revenue by Application (2017-2028)
9.3 Latin America Pegvisomant Market Size by Country
9.3.1 Latin America Pegvisomant Sales by Country (2017-2028)
9.3.2 Latin America Pegvisomant Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Pegvisomant Market Size by Type
10.1.1 Middle East and Africa Pegvisomant Sales by Type (2017-2028)
10.1.2 Middle East and Africa Pegvisomant Revenue by Type (2017-2028)
10.2 Middle East and Africa Pegvisomant Market Size by Application
10.2.1 Middle East and Africa Pegvisomant Sales by Application (2017-2028)
10.2.2 Middle East and Africa Pegvisomant Revenue by Application (2017-2028)
10.3 Middle East and Africa Pegvisomant Market Size by Country
10.3.1 Middle East and Africa Pegvisomant Sales by Country (2017-2028)
10.3.2 Middle East and Africa Pegvisomant Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Overview
11.1.3 Pfizer Pegvisomant Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Pfizer Pegvisomant Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Pegvisomant Industry Chain Analysis
12.2 Pegvisomant Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Pegvisomant Production Mode & Process
12.4 Pegvisomant Sales and Marketing
12.4.1 Pegvisomant Sales Channels
12.4.2 Pegvisomant Distributors
12.5 Pegvisomant Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Pegvisomant Industry Trends
13.2 Pegvisomant Market Drivers
13.3 Pegvisomant Market Challenges
13.4 Pegvisomant Market Restraints
14 Key Findings in The Global Pegvisomant Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

  • 本レポートと同分野の最新刊レポートはありません。

QYResearch社の
Fatal error: Uncaught TypeError: Cannot access offset of type string on string in /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/templates_c/58b4bde6a9738f3389cd7dea7f4ef5c62fdc6c54_0.file.auto_report.tpl.php:571 Stack trace: #0 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_resource_base.php(123): content_68a805fa34b2e0_16717164() #1 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_compiled.php(114): Smarty_Template_Resource_Base->getRenderedTemplateCode() #2 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_template.php(216): Smarty_Template_Compiled->render() #3 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_template.php(385): Smarty_Internal_Template->render() #4 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/templates_c/f20300271f4eb0fb4a2cf788aaabb06be5646d19_0.file.frame-FULL.tpl.php(278): Smarty_Internal_Template->_subTemplateRender() #5 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_resource_base.php(123): content_68a805fa26a288_46622063() #6 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_template_compiled.php(114): Smarty_Template_Resource_Base->getRenderedTemplateCode() #7 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_template.php(216): Smarty_Template_Compiled->render() #8 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_templatebase.php(238): Smarty_Internal_Template->render() #9 /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/libs/sysplugins/smarty_internal_templatebase.php(134): Smarty_Internal_TemplateBase->_execute() #10 /var/www/vhosts/dri.co.jp/httpdocs/auto/show_report.php(776): Smarty_Internal_TemplateBase->display() #11 {main} thrown in /var/www/vhosts/dri.co.jp/httpdocs/PHPLibs/Smarty/templates_c/58b4bde6a9738f3389cd7dea7f4ef5c62fdc6c54_0.file.auto_report.tpl.php on line 571